Opaleye Management Inc. Quant / Systematic

CIK: 0001595855 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 10, 2023

Total Value ($000): $287,572 (100.0% shares, 0.0% debt)

Holdings (40)

HROW HARROW HEALTH INC 19.4%
Value ($000) $55,719 Shares 3,775,000 Est. Cost $6.06 Unrealized +97.2%
TELA TELA BIO INC 8.3%
Value ($000) $23,837 Shares 2,072,813 Est. Cost $9.44 Unrealized -5.1%
RYTM RHYTHM PHARMACEUTICALS INC 7.4%
Value ($000) $21,403 Shares 735,000 Est. Cost $12.73 Unrealized +101.8%
OCUL OCULAR THERAPEUTIX INC 5.9%
Value ($000) $17,071 Shares 6,075,000 Est. Cost $5.00 Unrealized -33.8%
CRNX CRINETICS PHARMACEUTICALS INC 4.7%
Value ($000) $13,396 Shares 732,000 Est. Cost $20.83 Unrealized -15.4%
CYTK CYTOKINETICS INC 4.0%
Value ($000) $11,455 Shares 250,000 Est. Cost $18.45 Unrealized +132.9%
KROS KEROS THERAPEUTICS INC 4.0%
Value ($000) $11,429 Shares 238,000 Est. Cost $49.36 Unrealized -5.4%
PCVX VAXCYTE INC 3.0%
Value ($000) $8,487 Shares 177,000 Est. Cost $38.73 Unrealized +1.3%
BHVN BIOHAVEN LTD 2.6%
Value ($000) $7,495 Shares 540,000 Est. Cost $14.12 Unrealized 0.0%
FDMT 4D MOLECULAR THERAPEUTICS INC 2.5%
Value ($000) $7,329 Shares 330,000 Est. Cost $20.97 Unrealized -26.3%
TARA PROTARA THERAPEUTICS INC 2.5%
Value ($000) $7,216 Shares 2,692,594 Est. Cost $29.10 Unrealized -89.2%
TRACON PHARMACEUTICALS INC 2.4%
Value ($000) $6,839 Shares 4,590,000 Est. Cost $4.51 Unrealized
LRMR LARIMAR THERAPEUTICS INC 2.2%
Value ($000) $6,443 Shares 1,560,000 Est. Cost $7.31 Unrealized -53.3%
KALV KALVISTA PHARMACEUTICALS INC 2.2%
Value ($000) $6,241 Shares 923,200 Est. Cost $5.36 Unrealized 0.0%
ETON ETON PHARMACEUTICALS INC 2.1%
Value ($000) $6,119 Shares 2,170,000 Est. Cost $6.13 Unrealized -56.1%
EWTX EDGEWISE THERAPEUTICS INC 1.9%
Value ($000) $5,466 Shares 611,400 Est. Cost $10.83 Unrealized -13.4%
PRQR PROQR THERAPEUTICS NV 1.9%
Value ($000) $5,402 Shares 1,460,000 Est. Cost $3.64 Unrealized -64.1%
PHAT PHATHOM PHARMACEUTICALS INC 1.6%
Value ($000) $4,684 Shares 417,500 Est. Cost $10.31 Unrealized 0.0%
XOMA XOMA CORP DEL 1.6%
Value ($000) $4,471 Shares 243,000 Est. Cost $10.28 Unrealized +76.8%
CDXS CODEXIS INC 1.6%
Value ($000) $4,462 Shares 957,500 Est. Cost $3.62 Unrealized +51.2%
URGN UROGEN PHARMA LTD 1.5%
Value ($000) $4,334 Shares 488,656 Est. Cost $7.81 Unrealized +21.3%
KARYOPHARM THERAPEUTICS INC 1.5%
Value ($000) $4,282 Shares 1,206,841 Est. Cost $3.55 Unrealized
ASTRIA THERAPEUTICS INC 1.4%
Value ($000) $3,897 Shares 261,703 Est. Cost $11.91 Unrealized
LQDA LIQUIDIA CORPORATION 1.2%
Value ($000) $3,567 Shares 560,000 Est. Cost $5.49 Unrealized -2.1%
ZNTL ZENTALIS PHARMACEUTICALS INC 1.2%
Value ($000) $3,373 Shares 167,500 Est. Cost $21.51 Unrealized 0.0%
MARINUS PHARMACEUTICALS INC 1.1%
Value ($000) $3,288 Shares 826,200 Est. Cost $3.98 Unrealized
EDAP EDAP TMS S A 1.1%
Value ($000) $3,270 Shares 306,713 Est. Cost $10.10 Unrealized
WHWK AADI BIOSCIENCE INC 1.1%
Value ($000) $3,234 Shares 252,046 Est. Cost $13.06 Unrealized 0.0%
MORPHOSYS AG 1.1%
Value ($000) $3,210 Shares 896,600 Est. Cost $3.78 Unrealized
MERSANA THERAPEUTICS INC 0.9%
Value ($000) $2,696 Shares 460,000 Est. Cost $4.19 Unrealized
THESEUS PHARMACEUTICALS INC 0.9%
Value ($000) $2,664 Shares 535,000 Est. Cost $5.30 Unrealized
FENC FENNEC PHARMACEUTICALS INC 0.9%
Value ($000) $2,613 Shares 272,200 Est. Cost $8.85 Unrealized 0.0%
IDYA IDEAYA BIOSCIENCES INC 0.9%
Value ($000) $2,522 Shares 138,800 Est. Cost $16.78 Unrealized +0.2%
STXS STEREOTAXIS INC 0.9%
Value ($000) $2,453 Shares 1,185,000 Est. Cost $2.93 Unrealized -33.4%
BCAB BIOATLA INC 0.8%
Value ($000) $2,160 Shares 261,800 Est. Cost $8.30 Unrealized 0.0%
FORTRESS BIOTECH INC 0.5%
Value ($000) $1,343 Shares 2,050,000 Est. Cost $2.69 Unrealized
ALLAKOS INC 0.4%
Value ($000) $1,292 Shares 153,500 Est. Cost $6.12 Unrealized
TBPH THERAVANCE BIOPHARMA INC 0.3%
Value ($000) $983 Shares 87,600 Est. Cost $10.51 Unrealized 0.0%
TRVI TREVI THERAPEUTICS INC 0.3%
Value ($000) $936 Shares 485,000 Est. Cost $1.97 Unrealized 0.0%
MODD MODULAR MEDICAL INC 0.2%
Value ($000) $490 Shares 245,000 Est. Cost $3.92 Unrealized -23.2%